Yuandong Biological (688513.SH): Methylene blue injection receives FDA drug registration approval in the United States.

Smart Finance and Economics APP News, Yuandong Biological (688513.SH) announced that its wholly-owned subsidiary Chengdu Shuode Pharmaceutical Co., Ltd. (referred to as "Shuode Pharmaceutical") recently received a notification from the Food and Drug Administration of the United States (referred to as "FDA"). Shuode Pharmaceutical's Abbreviated New Drug Application (ANDA) for methylene blue injection submitted to the FDA has been officially approved.